Advanced Search

    Technical Analysis for LADX - Ladrx Corp

    Grade Last Price % Change Price Change
    F 0.1000 0.00% 0.0000
    LADX closed unchanged on Friday, January 27, 2023, on 80 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent N/A Down Down
    Historical LADX trend table...
    Date Alert Name Type % Chg
    Stochastic Buy Signal Bullish 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Bullish Engulfing Bullish 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    NR7 Range Contraction 11.11%
    NR7-2 Range Contraction 11.11%
    Narrow Range Bar Range Contraction 11.11%
    Older End-of-Day Signals for LADX ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    No Alerts Yet. Alerts will only show here if at least one person is tracking alerts on this stock.
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators Basic chart:

    Profile

    LadRx Corporation, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat patients with cancer. The company's advanced drug conjugate, aldoxorubicin that is in late-stage clinical trials is a version of anti-cancer drug doxorubicin. Its pre-clinical therapeutics comprise linker activated drug releases 7, 8, 9, and 10 targeted against cancer The company was formerly known as CytRx Corporation and changed its name to LadRx Corporation in September 2022. LadRx Corporation was incorporated in 1985 and is headquartered in Los Angeles, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Clinical Medicine Biopharmaceutical Chemotherapy Cancer Treatments Antineoplastic Drugs Doxorubicin Aldoxorubicin Cytrx

    Is LADX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 17 LadRx Corporation Issues Corporate Update for 3Q22
    See more LADX news...

    Indicators

    Indicator Value
    52 Week High 0.22
    52 Week Low 0.051
    Average Volume 103,220
    200-Day Moving Average 0.0000
    50-Day Moving Average 0.1510
    20-Day Moving Average 0.1172
    10-Day Moving Average 0.1130
    Average True Range 0.0264
    RSI 41.18
    ADX 13.9
    +DI 16.2243
    -DI 19.3933
    Chandelier Exit (Long, 3 ATRs) 0.0908
    Chandelier Exit (Short, 3 ATRs) 0.1302
    Upper Bollinger Bands 0.1564
    Lower Bollinger Band 0.0780
    Percent B (%b) 0.28
    BandWidth 66.8942
    MACD Line -0.0141
    MACD Signal Line -0.0122
    MACD Histogram -0.0019
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.1150
    Resistance 3 (R3) 0.1167 0.1133 0.1125
    Resistance 2 (R2) 0.1133 0.1095 0.1125 0.1117
    Resistance 1 (R1) 0.1067 0.1072 0.1050 0.1050 0.1108
    Pivot Point 0.1033 0.1033 0.1025 0.1025 0.1033
    Support 1 (S1) 0.0967 0.0995 0.0950 0.0950 0.0892
    Support 2 (S2) 0.0933 0.0972 0.0925 0.0883
    Support 3 (S3) 0.0867 0.0933 0.0875
    Support 4 (S4) 0.0850